Zentek (CVE:ZEN) Trading Up 16.3% – Still a Buy?

Shares of Zentek Ltd. (CVE:ZENGet Free Report) were up 16.3% during mid-day trading on Thursday . The company traded as high as C$1.70 and last traded at C$1.57. Approximately 121,928 shares were traded during trading, an increase of 271% from the average daily volume of 32,875 shares. The stock had previously closed at C$1.35.

Zentek Price Performance

The business’s fifty day simple moving average is C$1.48 and its 200-day simple moving average is C$1.33. The company has a current ratio of 2.06, a quick ratio of 7.59 and a debt-to-equity ratio of 4.97. The firm has a market cap of C$169.51 million, a P/E ratio of -15.57 and a beta of 0.77.

About Zentek

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

Read More

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.